205 related articles for article (PubMed ID: 26683593)
21. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
22. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
[TBL] [Abstract][Full Text] [Related]
23. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
24. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
25. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
26. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
[TBL] [Abstract][Full Text] [Related]
27. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV;
Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474
[TBL] [Abstract][Full Text] [Related]
28. Tissue plasminogen activator for acute ischemic stroke.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
N Engl J Med; 1995 Dec; 333(24):1581-7. PubMed ID: 7477192
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry.
Nezu T; Koga M; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Naganuma M; Minematsu K; Toyoda K
Neurology; 2010 Aug; 75(6):555-61. PubMed ID: 20697108
[TBL] [Abstract][Full Text] [Related]
30. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
Li YH; Li MH; Zhao JG; Wang W
J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
[TBL] [Abstract][Full Text] [Related]
31. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
Alexandrov AV; Wojner AW; Grotta JC;
J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.
Alexandrov AV; Molina CA; Grotta JC; Garami Z; Ford SR; Alvarez-Sabin J; Montaner J; Saqqur M; Demchuk AM; Moyé LA; Hill MD; Wojner AW;
N Engl J Med; 2004 Nov; 351(21):2170-8. PubMed ID: 15548777
[TBL] [Abstract][Full Text] [Related]
33. Increasing use of intravenous rt-PA does not affect safety in acute stroke.
Pfefferkorn T; Liebetrau M; Müllner A; Bender A; Hamann GF
J Neurol; 2005 Dec; 252(12):1500-3. PubMed ID: 16021352
[TBL] [Abstract][Full Text] [Related]
34. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
35. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
36. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
[TBL] [Abstract][Full Text] [Related]
37. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
[TBL] [Abstract][Full Text] [Related]
38. The clinical value of antiplatelet therapy for patients with hemorrhage after thrombolysis based on susceptibility-weighted imaging: a prospective pilot study.
Lu J; Li YH; Li YD; Li MH; Zhao JG; Chen SW
Eur J Radiol; 2012 Dec; 81(12):4094-8. PubMed ID: 22921680
[TBL] [Abstract][Full Text] [Related]
39. Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage.
Dunatov S; Antoncic I; Bralic M; Jurjevic A
Acta Neurol Scand; 2011 Nov; 124(5):343-8. PubMed ID: 21303348
[TBL] [Abstract][Full Text] [Related]
40. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]